Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Pruritus | Pruritus | 1.6% | x | x | |
| Folliculitis | Folliculitis | 0.3% | x | x | |
| Erythema | Erythema | 0.2% | x | x | |
| Dermatitis | Rash | x | x | ||
| Rash | Rash | x | x | ||
| Nodule | Nodule | x | x | ||
| Pain | Pain | x | x | ||
| Stinging | x | x | |||
| Dyshidrotic eczema | Dyshidrotic eczema | x | x | ||
| Dermatitis contact | Allergic contact dermatitis | x | x | ||
| Papule | Papule | x | x | ||
| Paraesthesia | Tingling sensation | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Body tinea | x | x | |||
| Infection | x | x | |||
| Pityriasis | x | x | |||
| Tinea cruris | x | x | |||
| Tinea infection | x | x | |||
| Tinea pedis | x | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |